SCA
MRK icon

Snowden Capital Advisors’s Merck MRK Stock Holding History

Snowden Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.4M Sell
135,191
-17,784
-12% -$2.05M 0.44% 34
2025
Q4 		$16.3M Buy
152,975
+61,004
+66% +$5.73M 0.42% 38
2025
Q3 		$7.8M Sell
91,971
-6,728
-7% -$554K 0.21% 94
2025
Q2 		$7.9M Sell
98,699
-9,178
-9% -$730K 0.23% 86
2025
Q1 		$9.77M Sell
107,877
-7,587
-7% -$708K 0.31% 61
2024
Q4 		$11.6M Sell
115,464
-10,963
-9% -$1.13M 0.36% 53
2024
Q3 		$14.5M Sell
126,427
-549
-0.4% -$65.2K 0.43% 39
2024
Q2 		$15.8M Sell
126,976
-5,978
-4% -$770K 0.47% 32
2024
Q1 		$17.6M Buy
132,954
+8,270
+7% +$1.02M 0.55% 24
2023
Q4 		$13.6M Sell
124,684
-4,120
-3% -$428K 0.52% 25
2023
Q3 		$13.3M Sell
128,804
-34,342
-21% -$3.7M 0.56% 26
2023
Q2 		$18.8M Buy
163,146
+13,179
+9% +$1.5M 0.67% 19
2023
Q1 		$16M Buy
149,967
+11,761
+9% +$1.27M 0.62% 23
2022
Q4 		$15.3M Buy
138,206
+3
+0% +$307 0.64% 20
2022
Q3 		$11.9M Buy
138,203
+8,411
+6% +$751K 0.54% 27
2022
Q2 		$11.8M Buy
129,792
+2,454
+2% +$218K 0.53% 30
2022
Q1 		$10.4M Buy
127,338
+72,389
+132% +$5.71M 0.42% 45
2021
Q4 		$4.21M Sell
54,949
-21,994
-29% -$1.75M 0.22% 147
2021
Q3 		$5.78M Buy
76,943
+5,625
+8% +$428K 0.29% 87
2021
Q2 		$5.55M Buy
71,318
+6,781
+11% +$504K 0.28% 95
2021
Q1 		$4.75M Buy
64,537
+6,445
+11% +$475K 0.27% 104
2020
Q4 		$4.53M Buy
58,092
+5,208
+10% +$398K 0.3% 95
2020
Q3 		$4.19M Sell
52,884
-1,066
-2% -$83.5K 0.34% 86
2020
Q2 		$3.98M Buy
53,950
+18,721
+53% +$1.41M 0.34% 88
2020
Q1 		$2.59M Buy
35,229
+7,612
+28% +$598K 0.28% 108
2019
Q4 		$2.4M Buy
27,617
+2,522
+10% +$207K 0.21% 144
2019
Q3 		$2.02M Buy
25,095
+5,738
+30% +$460K 0.2% 157
2019
Q2 		$1.55M Buy
19,357
+2,685
+16% +$206K 0.16% 194
2019
Q1 		$1.32M Sell
16,672
-353
-2% -$26.4K 0.14% 215
2018
Q4 		$1.24M Buy
17,025
+241
+1% +$17K 0.16% 206
2018
Q3 		$1.14M Sell
16,784
-514
-3% -$32.7K 0.13% 223
2018
Q2 		$1M Buy
17,298
+3
+0% +$169 0.13% 223
2018
Q1 		$899K Buy
17,295
+3,314
+24% +$179K 0.13% 209
2017
Q4 		$751K Sell
13,981
-557
-4% -$30.9K 0.11% 231
2017
Q3 		$888K Buy
14,538
+2,731
+23% +$166K 0.14% 199
2017
Q2 		$722K Buy
11,807
+1,781
+18% +$108K 0.14% 190
2017
Q1 		$608K Buy
10,026
+1,097
+12% +$66.6K 0.13% 198
2016
Q4 		$502K Sell
8,929
-17,904
-67% -$1.05M 0.13% 197
2016
Q3 		$1.6M Buy
26,833
+18,898
+238% +$1.11M 0.43% 78
2016
Q2 		$436K Sell
7,935
-4,965
-38% -$264K 0.13% 193
2016
Q1 		$651K Buy
+12,900
New +$632K 0.22% 150

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Snowden Capital Advisors's MRK Position: Q1 2026 in Review

Snowden Capital Advisors reduced its Merck (MRK) stake by 12% in Q1 2026, selling an estimated $2.05M and leaving 135,191 shares worth $16.4M. The position accounts for 0.44% of the portfolio, ranked #34.

Snowden Capital Advisors first reported a position in MRK in Q1 2016 and has held it in 41 quarters since. The position peaked at $18.8M in Q2 2023. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Snowden Capital Advisors held 135,191 shares of Merck worth $16.4M as of Q1 2026.
  • Snowden Capital Advisors sold 17,784 Merck shares in Q1 2026, an estimated $2.05M.
  • Merck made up 0.44% of Snowden Capital Advisors's portfolio in Q1 2026, its #34 holding.
  • Snowden Capital Advisors first reported a position in Merck in Q1 2016 and has held it in 41 quarters since.
  • Snowden Capital Advisors's Merck position peaked at $18.8M in Q2 2023.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.